NCT01460381View on ClinicalTrials.gov

A Study to Evaluate the Effect of Genotype on LY2216684

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Depressive Disorder, Major

Interventions

DRUG

LY2216684

DRUG

Quinidine

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01460381 - A Study to Evaluate the Effect of Genotype on LY2216684 | Biotech Hunter | Biotech Hunter